George C Eckert Ii

Array ( [id] => 4903959 [patent_doc_number] => 20080113372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'siRNA targeting glucagon receptor (GCGR)' [patent_app_type] => utility [patent_app_number] => 11/978475 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34180 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113372.pdf [firstpage_image] =>[orig_patent_app_number] => 11978475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903961 [patent_doc_number] => 20080113374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'siRNA targeting fructose-1,6-bisphosphatase 1 (FBP1)' [patent_app_type] => utility [patent_app_number] => 11/978487 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34239 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113374.pdf [firstpage_image] =>[orig_patent_app_number] => 11978487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122168 [patent_doc_number] => 07709629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)' [patent_app_type] => utility [patent_app_number] => 11/978398 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34327 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709629.pdf [firstpage_image] =>[orig_patent_app_number] => 11978398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83679 [patent_doc_number] => 07741306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Regulation of oncogenes by microRNAs' [patent_app_type] => utility [patent_app_number] => 11/876503 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 50 [patent_no_of_words] => 26136 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741306.pdf [firstpage_image] =>[orig_patent_app_number] => 11876503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608576 [patent_doc_number] => 07993831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Methods of normalization in microRNA detection assays' [patent_app_type] => utility [patent_app_number] => 11/855792 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16078 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993831.pdf [firstpage_image] =>[orig_patent_app_number] => 11855792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10615088 [patent_doc_number] => 09334522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Agents and methods to elicit anti-tumor immune response' [patent_app_type] => utility [patent_app_number] => 12/441335 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 41 [patent_no_of_words] => 33587 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12441335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676854 [patent_doc_number] => 20080214485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Method of inducing an immune response' [patent_app_type] => utility [patent_app_number] => 11/900412 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10539 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214485.pdf [firstpage_image] =>[orig_patent_app_number] => 11900412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824846 [patent_doc_number] => 20080124301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Method for stimulating the immune system' [patent_app_type] => utility [patent_app_number] => 11/898080 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 3491 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124301.pdf [firstpage_image] =>[orig_patent_app_number] => 11898080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099623 [patent_doc_number] => 08563500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Methods and compounds for treating diseases caused by reactive oxygen species' [patent_app_type] => utility [patent_app_number] => 12/676617 [patent_app_country] => US [patent_app_date] => 2007-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 10 [patent_no_of_words] => 16628 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458777 [patent_doc_number] => 20090258929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Compositions and Methods for Modulating mTOR Signaling' [patent_app_type] => utility [patent_app_number] => 12/439621 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12360 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258929.pdf [firstpage_image] =>[orig_patent_app_number] => 12439621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11548746 [patent_doc_number] => 09617581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Methods for in vivo identification of endogenous mRNA targets of MicroRNAs' [patent_app_type] => utility [patent_app_number] => 12/438383 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10848 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12438383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880388 [patent_doc_number] => 20080153771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases' [patent_app_type] => utility [patent_app_number] => 11/894567 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 20307 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153771.pdf [firstpage_image] =>[orig_patent_app_number] => 11894567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4895632 [patent_doc_number] => 20080104732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'METHODS AND MEANS FOR OBTAINING MODIFIED PHENOTYPES' [patent_app_type] => utility [patent_app_number] => 11/841737 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18717 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20080104732.pdf [firstpage_image] =>[orig_patent_app_number] => 11841737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899821 [patent_doc_number] => 20080119435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'HES6 AS A MARKER OF PANCREATIC ENDOCRINE CELLS' [patent_app_type] => utility [patent_app_number] => 11/835391 [patent_app_country] => US [patent_app_date] => 2007-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12364 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119435.pdf [firstpage_image] =>[orig_patent_app_number] => 11835391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4687640 [patent_doc_number] => 20080031821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/779069 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19576 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20080031821.pdf [firstpage_image] =>[orig_patent_app_number] => 11779069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102658 [patent_doc_number] => 07723315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Modulators of coagulation factors' [patent_app_type] => utility [patent_app_number] => 11/821183 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 23573 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723315.pdf [firstpage_image] =>[orig_patent_app_number] => 11821183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6584078 [patent_doc_number] => 20100047783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'SMALL MOLECULE MODULATORS OF P53 FAMILY SIGNALING' [patent_app_type] => utility [patent_app_number] => 12/306173 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12660 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047783.pdf [firstpage_image] =>[orig_patent_app_number] => 12306173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823657 [patent_doc_number] => 20080227967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)' [patent_app_type] => utility [patent_app_number] => 11/818555 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 34762 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227967.pdf [firstpage_image] =>[orig_patent_app_number] => 11818555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391133 [patent_doc_number] => 20090208446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'DUB3 as a Cancer Therapy Target' [patent_app_type] => utility [patent_app_number] => 12/227258 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13615 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208446.pdf [firstpage_image] =>[orig_patent_app_number] => 12227258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4471262 [patent_doc_number] => 07943762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Oligonucleotide analogs having cationic intersubunit linkages' [patent_app_type] => utility [patent_app_number] => 11/801885 [patent_app_country] => US [patent_app_date] => 2007-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 48975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943762.pdf [firstpage_image] =>[orig_patent_app_number] => 11801885 [rel_patent_id] =>[rel_patent_doc_number] =>)